Gerresheimer

News

Newel Health and Gerresheimer ally to help pharma firms embed digital endpoints, real-world data, and AI into clinical testing and commercialisation.

News

Just weeks after forming as a spinout from Endevica Bio, obesity drug developer Kalohexis has filed for an IPO.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.